Primary tumors with BRAF mutations had significantly higher levels of methylation than BRAF wild-type tumors, while TP53 mutant tumors had lower levels of methylation than wild-type TP53 tumors, although these differences did not reach statistical significance in cell lines (Additional file 1 : Fig.
← all excerpts
Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis.
1
—
—